Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Zhao, Yue  [Clear All Filters]
Journal Article
Zhao L, Zhao Y, Schwarz B, Mysliwietz J, Hartig R, Camaj P, Bao Q, Jauch K-W, Guba M, Ellwart JWalter, et al. Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells. Int J Oncol. 2016.
Zhao Y, Dong Q, Li J, Zhang K, Qin J, Zhao J, Sun Q, Wang Z, Wartmann T, Jauch KWalter, et al. Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies. Semin Cancer Biol. 2018.
Wang Y, Zhao Y, Herbst A, Kalinski T, Qin J, Wang X, Jiang Z, Benedix F, Franke S, Wartman T, et al. miR-221 Mediates Chemoresistance of Esophageal Adenocarcinoma by Direct Targeting of DKK2 Expression. Ann Surg. 2016.
Xu W, Ji J, Xu Y, Liu Y, Shi L, Liu Y, Lu X, Zhao Y, Luo F, Wang B, et al. MicroRNA-191, by promoting the EMT and increasing CSC-like properties, is involved in neoplastic and metastatic properties of transformed human bronchial epithelial cells. Mol Carcinog. 2014.
Zhao Y, Gao C, Liu H, Liu H, Feng Y, Li Z, Liu H, Wang J, Yang B, Lin Q. Infliximab-based Self-healing Hydrogel Composite Scaffold Enhances Stem Cell Survival, Engraftment, and Function in Rheumatoid Arthritis Treatment. Acta Biomater. 2020.
Paul B, Zhao Y, Loitsch G, Feinberg D, Mathews P, Barak I, Dupuis M, Li Z, Rein L, Wang E, et al. The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors. Cancer Med. 2020.
Kong F-E, Tang Y-Q, Gong Y-F, Mo J-Q, Zhao Y, Li M-M, Cheng W, Li H-L, Zhu W-J, Liu S-S, et al. Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model. Hepatol Int. 2020.
Yu Y, Gao Q, Zhao H-C, Li R, Gao J-M, Ding T, Bao S-Y, Zhao Y, Sun X-F, Fan Y, et al. Erratum to: Ascorbic acid improves pluripotency of human parthenogenetic embryonic stem cells through modifying imprinted gene expression in the Dlk1-Dio3 region. Stem Cell Res Ther. 2015;6(1):180.
Robledo RF, Ciciotte SL, Graber JH, Zhao Y, Lambert AJ, Gwynn B, Maki NJ, Brindley EC, Hartman E, Blanc L, et al. Differential effects of RASA3 mutations on hematopoiesis are profoundly influenced by genetic background and molecular variant. PLoS Genet. 2020;16(12):e1008857.
Chen Q, Wang J, Liu WNam, Zhao Y. Cancer Immunotherapies and Humanized Mouse Drug Testing Platforms. Transl Oncol. 2019;12(7):987-995.
Yin F, Yan J, Zhao Y, Guo K-J, Zhang Z-L, Li A-P, Meng C-Y, Guo L. Bone marrow mesenchymal stem cells repair Cr (VI)- injured kidney by regulating mitochondria-mediated apoptosis and mitophagy mediated via the MAPK signaling pathway. Ecotoxicol Environ Saf. 2019;176:234-241.
Zhao Y, Yan J, Li A-P, Zhang Z-L, Li Z-R, Guo K-J, Zhao K-C, Ruan Q, Guo L. Bone marrow mesenchymal stem cells could reduce the toxic effects of hexavalent chromium on the liver by decreasing endoplasmic reticulum stress-mediated apoptosis via SIRT1/HIF-1α signaling pathway in rats. Toxicol Lett. 2019.
Zhao Y, Luo B. Adipose-derived stem cells: A novel source of parathyroid cells for treatment of hypoparathyroidism. Med Hypotheses. 2016;93:143-145.